Workhorse Group Sets Fourth Quarter and Full Year 2022
CINCINNATI, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Workhorse Group Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company focused......
Ecobot Earns 2022 EBJ Business Achievement Award
ASHEVILLE, N.C., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Ecobot, the premier digital solution for mandatory pre-construction assessments, has received a 2022......
Kura Oncology to Report Fourth Quarter and Full Year 2022
SAN DIEGO, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the......
Intellia Therapeutics to Hold Conference Call to Discuss
CAMBRIDGE, Mass., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on......
Decibel Therapeutics to Present at the Upcoming SVB
BOSTON, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and......
Shattuck Labs to Report Fourth-Quarter and Full-Year 2022
AUSTIN, TX & DURHAM, NC, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company......
WatchGuard Launches New Line of Firewall Products to
Powered by WatchGuard’s Unified Security Platform® architecture, new Fireboxes deliver enhanced performance and added security capabilities that MSPs and......
GA-ASI Partners With Divergent Technologies, Inc.
UAS Leader Integrates DAPS Digital Manufacturing Process......
Emergent BioSolutions Reports FDA Advisory Committees’
If approved by the FDA, NARCAN Nasal Spray will be the first 4 mg naloxone nasal spray switched from prescription status to over-the-counter use ......
Atea Pharmaceuticals to Present Data on Bemnifosbuvir Drug
BOSTON, Feb. 15, 2023 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company, today announced......